ArticleClinical pharmacokinetics2015

Clinical and preclinical pharmacokinetics and pharmacodynamics of mipomersen (kynamro(®)): a second-generation antisense oligonucleotide inhibitor of apolipoprotein B.

Richard S Geary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.